NEONATAL JAUNDICE; PREVALENC AND ITS ASSOCIATED RISK FACTOR AS SEEN IN OMDURMAN MATERNITY HOSPITAL
NEONATAL JAUNDICE; PREVALENC AND ITS ASSOCIATED RISK FACTOR AS SEEN IN OMDURMAN MATERNITY HOSPITAL
No Thumbnail Available
Date
2021
Authors
Aisha Adam Saad
Rafa Alhadry Ali
Hibatallah Bdraldeen Altegani
Journal Title
Journal ISSN
Volume Title
Publisher
Napata College
Abstract
Background and objectives: Neonatal jaundice affects one in two infants globally. The jaundice is the result of an accumulation of bilirubin as fetal hemoglobin is metabolized by the immature liver. High serum levels of bilirubin result in lethargy, poor feeding and kernicterus of the infant. The main aim of this study was to determine the prevalence of neonatal jaundice and to explore its associated risk factors and management Materials and methods: This institution based cross-sectional study was conducted to at neonatal intensive care unit of Omdurman Maternity Hospital during first 6 months of 2019. A sample of 102 neonates was selected for the study purpose. The data was collected using a data collection sheet. Data was analyzed using SPSS v24. Results: The majority of the mothers (64.7%) were from urban areas, 82.7% of the births took place in a health facility, and 50% gave birth via spontaneous vaginal delivery (SVD). Mothers were mostly (44.1%) of type AB blood group. The majority of the neonates were males (53.9%). 66.7% were born at 37-42 weeks. The major treatment for increased serum bilirubin were IVIg (48%) and phototherapy (29.4%). The Serum bilirubin levels were high at 10-22 5mg/dl. Having mothers from rural areas (p=0.00), multiple pregnancies(p=0.00), born at home (p=0.01) and caesarean section delivery (p=0.02) were positively associated with neonatal jaundice.
Conclusion: Place of living, multiple pregnancy, place of delivery, and mode of delivery were associated with neonatal jaundice. IVIg and phototherapy were the major treatments for neonatal jaundice. The study recommended provision of access to prenatal and postnatal services, particularly in rural areas, and use of phototherapy as the initial therapy to treat hyperbilirubinemia.